Cartesian President & CEO Murat Kalayoglu, M.D., Ph.D. has led three of his company’s six autoimmune, oncology, and respiratory candidates through Phase I/II clinical trials and two more of them are on the cusp of entering Phase I this year. With so many programs in and entering the clinic, he’s a great choice for a […]

South San Francisco-based clinical-stage biotechnology company Sutro Biopharma has received a milestone payment under its collaboration and license agreement with the healthcare division of Merck KGaA, Darmstadt, Germany. The novel agent is being developed for the treatment of adult patients with metastatic solid tumors, including non-small cell lung cancer (NSCLC) and esophageal squamous cell carcinoma. […]

Collegeville resident Tracy Augustine had received the devastating news of her stage two breast cancer just as the pandemic was shutting the world down last year. After going through a double mastectomy, radiation and chemotherapy she faced the possibility of contracting lymphedema, a painful condition characterized by swelling and the buildup of fluid in the […]